Article
GIPR Gene Polymorphism and Weight Gain in Patients With Schizophrenia Treated With Olanzapine.
The Journal of neuropsychiatry and clinical neurosciences - 1 Jan 2015
Ono Shin, Suzuki Yutaro, Fukui Naoki, Sawamura Kazushi, Sugai Takuro, Watanabe Junzo, Tsuneyama Nobuto, Someya Toshiyuki
Abstract excerpt
Association between gastric inhibitory polypeptide receptor polymorphism, rs10423928, and body mass index in olanzapine-treated schizophrenia was examined. Body mass index change for the A/T+A/A genotypes was significantly higher than that for the T/T genotype. rs10423928 may predict weight gain in schizophrenia.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
